CEPHALEXIN (sef-a-lex'in) Ceporex A, Keflex, Novolexin A Classifications: beta-lactam antibiotic; first-generation cephalosporin; Therapeutic: antibiotic; cephalosporin Prototype: Cefazolin Pregnancy Category: B |
250 mg, 500 mg capsules; 250 mg, 500 mg, 1 g tablets; 125 mg/5 mL, 250 mg/5 mL suspension
Semisynthetic beta-lactam cephalosporin. Preferentially binds to one or more of the penicillin-binding proteins (PBP) located on cell walls of susceptible organisms. This inhibits third and final stage of bacterial cell wall synthesis, thus killing the bacterium.
Broad-spectrum, first-generation cephalosporin antibiotic active against many gram-positive aerobic cocci and much less active against gram-negative bacteria or anaerobic organisms.
To treat infections caused by susceptible pathogens in respiratory and urinary tracts, middle ear, skin, soft tissue, and bone.
Hypersensitivity to cephalosporins and related antibiotics; viral infections. Safe use in infants <1 mo not established.
History of hypersensitivity to penicillin or other drug allergy; severely impaired renal function; GI disease, colitis; hepatic disease; coagulopathy; pregnancy (category B), lactation.
Mild to Moderate Infection Adult: PO 250500 mg q6h Child: PO 25100 mg/kg/d in 4 divided doses Skin and Skin Structure Infections Adult: PO 500 mg q12h Otitis Media Child: PO 75100 mg/kg/d in 4 divided doses |
False-positive urine glucose determinations using copper sulfate reagents (e.g., Clinitest, Benedict's reagent), but not with glucose oxidase (enzymatic) tests (e.g., TesTape, Diastix, Clinistix). Positive direct Coombs' test may complicate transfusion cross-matching procedures and hematologic studies.
Assessment & Drug Effects
Patient & Family Education